Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up

By Davidkin I.   Valle M.   Julkunen I.  

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1617-1622

Elsevier

Access to resources Recommend Favorite

Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts

By Davidkin I.   Valle M.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 2052-2057

Elsevier

Access to resources Recommend Favorite

Familial adverse events after measles-mumps-rubella (MMR) vaccination

By Guala A.   Garipoli V.   Pastore G.   Pagani L.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 991-991

Elsevier

Access to resources Recommend Favorite

Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance

By Pebody R.G.   Gay N.J.   Hesketh L.M.   Vyse A.   Morgan-Capner P.   Brown D.W.   Litton P.   Miller E.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1134-1140

Elsevier

Access to resources Recommend Favorite

Immunity to rubella before and after vaccination against measles, mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 months

By Bottiger M.  

Vaccine, Vol. 13, Iss. 18, 1995-01 ,pp. : 1759-1762

Elsevier

Access to resources Recommend Favorite